MedPath

Divergent Low Level Laser Therapy as novel treatment for oral mucositis in patients with oral or oropharyngeal squamous cell carcinoma’

Conditions
Oral mucositis in oral or oropharyngeal squamous cell carcinoma
Registration Number
NL-OMON21094
Lead Sponsor
Stichting Overleven
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
70
Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•Subjects should have a primary O/OPSCC
•Subjects who are scheduled for RT
•Subjects who are competent
•Subjects should be aged 18 years or older

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:
•O/OPSCC recurrence after primary O/OPSCC treatment
•Unable to read Dutch
•Unable to complete the questionnaires

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The severity of oral mucositis
Secondary Outcome Measures
NameTimeMethod
othe number of days with OM (M0-M9)<br>othe number of oral infections (M0-M9)<br>ooral hygiene (M0-M9)<br>opain (VASpain; M0-M9)<br>oxerostomia (M0, M4, M8, and M9)<br>omaximum mouth opening (MMO) (M0, M4, M8, and M9)<br>otaste (M0, M4, M8, and M9)<br>oquality of life (M0, M4, M8, and M9)<br>
© Copyright 2025. All Rights Reserved by MedPath